コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 atically isolated from lean, healthy Ossabaw miniature swine.
2 ng and smell, at rest and during exercise in miniature swine.
3 n) using L-[1-13C]Leu as a tracer in 24 male miniature swine.
4 allografts procured from healthy MHC-inbred miniature swine.
5 poiesis and provide long-term engraftment in miniature swine.
6 cs of PBSCs were determined in 2-5-month-old miniature swine.
7 ft and support host thymopoiesis in euthymic miniature swine.
8 dies of allogeneic thymic transplantation in miniature swine.
9 ng-lasting acceptance of renal allografts in miniature swine.
10 implanted in the iliac arteries of nine NIH miniature swine.
11 tal major histocompatibility complex-defined miniature swine.
12 ajor histocompatibility complex (MHC)-inbred miniature swine.
13 lpha-1,3-galactosyltransferase gene knockout miniature swine.
14 to fully MHC-mismatched renal transplants in miniature swine.
15 combined immunodeficient (NOD/SCID) mice and miniature swine.
16 eneic stem cell or spleen transplantation in miniature swine.
17 ajor histocompatibility complex (MHC)-inbred miniature swine.
18 lity complex (MHC) mismatch in thymectomized miniature swine.
19 f antibodies to non-MHC antigens in tolerant miniature swine.
20 eactivity against either standard or GalT-KO miniature swine.
21 ormed across a class I MHC barrier in inbred miniature swine.
22 es and maintains tolerance to both organs in miniature swine.
23 larized thymic lobe (VTL) transplantation in miniature swine.
24 e tissue allografts across an MHC barrier in miniature swine.
25 an intact, vascularized thymic lobe (VTL) in miniature swine.
26 nts were present in the genomic DNA of these miniature swine.
27 to six MHC-matched, minor antigen-mismatched miniature swine.
28 x (MHC)- mismatched barriers in juvenile MGH-miniature swine.
29 vascularized thymic lobe transplantation in miniature swine.
30 n both "tolerant" and "nontolerant" chimeric miniature swine.
31 thout the need for whole body irradiation in miniature swine.
32 l of chronic lung rejection using MHC-inbred miniature swine.
33 lanted beneath the renal capsule of juvenile miniature swine.
34 isease across MHC barriers in mixed chimeric miniature swine.
35 pic lung transplants (n=3) were performed in miniature swine across a major histocompatibility comple
36 leen transplantation (SpTx) was performed in miniature swine across full major histocompatibility com
37 or reactivity against: 1) human; 2) standard miniature swine; and 3) GalT-KO peripheral blood lymphoc
40 ere implanted in the coronary arteries of 31 miniature swine at 28 days after creation of a fibrocell
41 immunotoxin was administered i.v. to several miniature swine at doses ranging from 0.15-0.2 mg/kg eit
42 sis of Hoechst dye-stained human, rhesus and miniature swine bone marrow cells reveals a small, disti
43 toxin provides excellent T-cell depletion in miniature swine but is associated with significant dose-
44 ismatched renal allografts can be induced in miniature swine by treatment with a short course of cycl
45 nce of class I disparate renal allografts in miniature swine can be induced by a short course of cycl
46 nce to class I-disparate renal allografts in miniature swine can be induced by a short course of cycl
47 rs for cloning, resulting in the creation of miniature swine containing mono- and biallelic mutations
51 1,3 galactosyltransferase knockout (GalT-KO) miniature swine enjoyed survival comparable to that of a
52 s II identical renal grafts is achievable in miniature swine following a short immunosuppressive trea
53 promised mice for one tumor cell line and in miniature swine for 1 of 2 tumor cell lines expanded for
55 Over the last 40 y, a specialized herd of miniature swine has been intentionally bred to develop l
56 1,3-galactosyltransferase knockout (GalT-KO) miniature swine has eliminated anti-Gal antibodies as th
61 The identification of animals in an inbred miniature swine herd that consistently fail to produce r
62 these recombinants are exogenous viruses in miniature swine; i.e., they are not present in the germ
64 he family of study were not present in other miniature swine in the herd that produced humantropic PE
65 immunosuppression and used partially inbred miniature swine, in which the genetics of major histocom
66 ion between swine leukocyte Ag (SLA)-matched miniature swine, in which tolerance can be established w
67 d recombinant PERV-A/C loci in the genome of miniature swine, indicate that exogenous PERV is the pri
68 ce of class I mismatched renal allografts in miniature swine is induced by a short course of cyclospo
69 te systemic tolerance to renal allografts in miniature swine is induced in 100% of cases across a two
70 or-specific tolerance to renal allografts in miniature swine is uniformly induced across a two-haplot
71 rus transplantation in a large animal model (miniature swine) is feasible using this heterotopic mode
74 ajor histocompatibility complex (MHC) inbred miniature swine large animal model that the construction
75 hed against PAEC from partially inbred SLAdd miniature swine lysed only PAEC and phytohemagglutinin-s
78 investigation was to establish a transgenic miniature swine model of RP using the human P23H RHO gen
79 n RHO P23H transgene in the retina creates a miniature swine model with an inheritance pattern and re
80 re, we demonstrate, in a clinically relevant miniature swine model, induction of immunologic toleranc
81 inary results show that in this well-defined miniature swine model, recombinant swine cytokine combin
83 in fractions in different organs, we infused miniature swine (n = 8 per group) with saline, insulin a
84 C) obtained by leukapheresis from MHC-inbred miniature swine (n=6) were transplanted into baboons.
85 both major histocompatibility complex-inbred miniature swine (n=7) and human decay-accelerating facto
86 1 region was found to be invariant among MGH miniature swine of different haplotypes, despite 25 year
87 (P1 and P14) obtained from homozygous inbred miniature swine of three haplotypes (aa, cc, and dd), re
92 ted human cells following cocultivation with miniature swine peripheral blood mononuclear cells (PBMC
102 jor histocompatibility complex (MHC)-defined miniature swine received haploidentical hematopoietic ce
108 on of mixed chimerism across MHC barriers in miniature swine, severe graft-versus-host disease was av
109 ly retransplanted into MHC-matched, diabetic miniature swine, similar in weight to the original recip
111 NA transcript profiles in a family of inbred miniature swine (SLA(d/d) haplotype) in which individual
116 Here we report the identification of inbred miniature swine that failed to produce human-tropic repl
117 of animals within a research herd of inbred miniature swine that lack the capacity to transmit PERV
119 enomic DNA libraries were generated from one miniature swine that transmitted HTRC PERV as well as fr
120 These viruses were invariably present in miniature swine that transmitted PERV to human cells and
123 ated whether tolerance could be generated in miniature swine to composite tissue allografts across a
125 otransplantation were carried out in Yucatan miniature swine to explore the effects of IDN6556 on isl
126 eloped a surgical technique for spleen Tx in miniature swine to investigate its immunologic impact in
127 neys were transplanted from Gal-positive MGH miniature swine to MGH GalT-KO swine with systemic immun
129 jor histocompatibility complex (MHC)-matched miniature swine treated with 12 days of cyclosporine.
130 ce of class I-mismatched renal allografts in miniature swine treated with 12 days of high dose Cyclsp
131 into major histocompatibility complex-inbred miniature swine treated with a 12-day course of cyclospo
132 involved in tolerance to renal allografts in miniature swine treated with a short course of calcineur
133 C class I disparate hearts transplanted into miniature swine treated with a short course of cyclospor
134 This study found a high incidence of PTLD in miniature swine undergoing allogeneic hematopoietic stem
140 previously demonstrated T-cell depletion in miniature swine using a CRM9-based CD3-immunotoxin, pCD3
141 full MHC-mismatch barrier was established in miniature swine using a high-dose allogeneic peripheral
143 nor-specific tolerance can be established in miniature swine, using a relatively mild, non-myeloablat
144 ning stable mixed hematopoietic chimerism in miniature swine, using MHC-matched donors and recipients
145 ogenicity of MHC alloantigens in MHC-defined miniature swine via primary and secondary MLR culture as
147 m Massachusetts General Hospital MHC-defined miniature swine, we assessed immunogenicity across a ful
148 llograft induces tolerance to both organs in miniature swine, we examined the renal elements responsi
150 d islet-kidney (IK) transplantation model in miniature swine, we studied whether an islet-toxic tripl
152 peripheral blood stem cell transplantation, miniature swine were conditioned with thymic irradiation
157 reported that Massachusetts General Hospital miniature swine, which had accepted class I-mismatched k
158 safety of clinical xenotransplantation from miniature swine will be most enhanced by the utilization
161 pe class I disparity is uniformly induced in miniature swine with a short course of cyclosporine (CsA
162 cular response to the Multi-Link stent in 19 miniature swine with experimentally induced coronary ath
163 mestic farm pigs and between pairs of inbred miniature swine with genetically defined major histocomp
165 ograft vasculopathy, we immunized MHC inbred miniature swine with synthetic polymorphic peptides span
166 Tissue-engineered arteries were implanted in miniature swine, with patency documented up to 24 days b
168 derived iPSCs from fibroblasts of Wisconsin miniature swine (WMS), Yucatan miniature swine (YMS), an
171 of Wisconsin miniature swine (WMS), Yucatan miniature swine (YMS), and Gottingen minipigs (GM) using